The Clorox CompanyCLXNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-12.50%
↓ 1432% below average
Average (39q)
0.94%
Historical baseline
Range
High:40.63%
Low:-26.67%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -12.50% |
| Q2 2025 | 18.52% |
| Q1 2025 | -12.90% |
| Q4 2024 | 0.00% |
| Q3 2024 | -6.06% |
| Q2 2024 | 3.13% |
| Q1 2024 | 0.00% |
| Q4 2023 | 10.34% |
| Q3 2023 | -23.68% |
| Q2 2023 | 8.57% |
| Q1 2023 | 6.06% |
| Q4 2022 | 3.13% |
| Q3 2022 | -5.88% |
| Q2 2022 | 9.68% |
| Q1 2022 | -8.82% |
| Q4 2021 | 3.03% |
| Q3 2021 | -26.67% |
| Q2 2021 | 40.63% |
| Q1 2021 | -20.00% |
| Q4 2020 | 25.00% |
| Q3 2020 | -23.81% |
| Q2 2020 | 7.69% |
| Q1 2020 | 14.71% |
| Q4 2019 | 13.33% |
| Q3 2019 | -21.05% |
| Q2 2019 | 11.76% |
| Q1 2019 | 6.25% |
| Q4 2018 | 0.00% |
| Q3 2018 | -13.51% |
| Q2 2018 | 15.63% |
| Q1 2018 | 3.23% |
| Q4 2017 | -3.13% |
| Q3 2017 | -13.51% |
| Q2 2017 | 5.71% |
| Q1 2017 | 9.38% |
| Q4 2016 | 3.23% |
| Q3 2016 | -26.19% |
| Q2 2016 | 20.00% |
| Q1 2016 | 2.94% |
| Q4 2015 | 13.33% |